FDA Drug Safety Podcasts
50 Followers
35 Episodes
Follow Share 
50
Followers
35
Episodes
Category: Medicine
Last Update: 2024-02-06
Claim Ownership

FDA Drug Safety Podcasts, produced by FDA's Center for Drug Evaluation and Research, provide emerging safety information about drugs in conjunction with the release of Drug Safety Communications. For more information, please visit: www.fda.gov/drugsafetypodcasts

1 FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab) 2024-02-06
Play

Download
2 Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity 2024-01-26
Play

Download
3 FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan) 2023-12-08
Play

Download
4 FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions 2023-05-31
Play

Download
5 FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use 2023-05-10
Play

Download
6 FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab) 2022-12-16
Play

Download
7 FDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns 2022-07-07
Play

Download
8 FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging 2022-04-13
Play

Download
9 FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) 2022-02-09
Play

Download
10 FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain 2022-01-24
Play

Download